Literature DB >> 12616600

Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India.

B Lakshmi1, T A Ajith, N Sheena, Nidhi Gunapalan, K K Janardhanan.   

Abstract

Free radical mediated genetic instability is widely thought to be a major etiological factor for initiation of carcinogenesis. Mushrooms represent a largely untapped source of powerful new pharmaceutical products. In the present study, we examined the antiperoxidative, anti-inflammatory, and antimutagenic activities of the ethanol extract of the mycelium of a medicinal mushroom, Ganoderma lucidum, occurring in south India. Antiperoxidative activity was evaluated using Fe(2+)-ascorbate-induced lipid peroxidation in rat liver homogenate and a phorbol ester (croton oil)-induced lipid peroxidation in mouse skin. Antiinflammatory activity was evaluated against carrageenan-induced acute and formalin-induced chronic inflammatory paw edema in mouse and phorbol ester-induced mouse skin inflammation. Antimutagenic activity was determined by the Ames mutagenicity assay using histidine mutant of Salmonella typhimurium strains TA 98, TA100, and TA102. Sodium azide (NaN(3)), N-methyl-N-nitro-N-nitrosoguanidine (MNNG), 4-nitro-o-phenylenediamine (NPD), and benzo[a]pyrene (B[a]P) were used as the mutagens. The extract showed significant inhibition of Fe(2+)-induced peroxidation of lipid in rat liver (IC(50) 510 +/- 22 microg/ml) and 37% inhibition of croton oil-induced peroxidation on the mouse skin at 20 mg/0.1 ml/skin. Carrageenan-induced acute and formalin-induced chronic inflammatory edema were inhibited by 56 and 60%, respectively, by the extract at 1,000 mg/kg body wt (i.p). The extract at a concentration of 5 mg/plate showed inhibition of mutagenicity elicited by direct acting mutagens, NaN(3) (55.5 and 75.7%) and MNNG (50.0 and 57.5%) for S. typhymurium strains TA100 and TA102, respectively. The extract at the same concentration also inhibited mutagenicity elicited by NPD (52.4 and 64.2%) and B[a]P (60.7 and 59.6%) for TA98 and TA100 strains, respectively. The B[a]P was activated in the presence of rat liver microsomal (S9) fraction. The results of our study revealed that ethanol extract of Ganoderma lucidum mycelium possessed significant antiperoxidative, antiinflammatory, and antimutagenic activities. The findings suggest a medicinal use for the ethanol extract of the mycelium of G. lucidum occurring in South India. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616600     DOI: 10.1002/tcm.10065

Source DB:  PubMed          Journal:  Teratog Carcinog Mutagen        ISSN: 0270-3211


  16 in total

1.  Effects of a water-soluble extract of Ganoderma lucidum mycelia on aberrant crypt foci induced by azoxymethane and small-intestinal injury by 5-FU in F344 rats.

Authors:  Hiromitsu Watanabe; Naoki Kashimoto; Mitsuyasu Ushijima; Koichi Tamura
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

2.  Agaricus brasiliensis (sun mushroom) affects the expression of genes related to cholesterol homeostasis.

Authors:  Aline Mayrink de Miranda; Joamyr Victor Rossoni Júnior; Lorena Souza E Silva; Rinaldo Cardoso Dos Santos; Marcelo Eustáquio Silva; Maria Lúcia Pedrosa
Journal:  Eur J Nutr       Date:  2016-05-05       Impact factor: 5.614

3.  Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms.

Authors:  Chih-Ching Chien; Mei-Ling Tsai; Chin-Chu Chen; Shing-Jyh Chang; Ching-Hui Tseng
Journal:  Mycopathologia       Date:  2008-05-06       Impact factor: 2.574

4.  A water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia attenuates the small intestinal injury induced by anti-cancer drugs.

Authors:  Naoki Kashimoto; Satomi Ishii; Yuki Myojin; Mitsuyasu Ushijima; Minoru Hayama; Hiromitsu Watanabe
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

5.  Photomutagenicity of 16 polycyclic aromatic hydrocarbons from the US EPA priority pollutant list.

Authors:  Jian Yan; Lei Wang; Peter P Fu; Hongtao Yu
Journal:  Mutat Res       Date:  2004-01-10       Impact factor: 2.433

6.  Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast.

Authors:  Y W Ho; J S L Yeung; P K Y Chiu; W M Tang; Z B Lin; R Y K Man; C S Lau
Journal:  Mol Cell Biochem       Date:  2007-01-12       Impact factor: 3.842

Review 7.  Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.

Authors:  Nerida L Klupp; Dennis Chang; Fiona Hawke; Hosen Kiat; Huijuan Cao; Suzanne J Grant; Alan Bensoussan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-17

8.  Anti-inflammatory effect of the sclerotium of Lignosus rhinocerotis (Cooke) Ryvarden, the Tiger Milk mushroom.

Authors:  Sook Shien Lee; Nget Hong Tan; Shin Yee Fung; Si Mui Sim; Chon Seng Tan; Szu Ting Ng
Journal:  BMC Complement Altern Med       Date:  2014-09-25       Impact factor: 3.659

9.  Indian medicinal mushrooms as a source of antioxidant and antitumor agents.

Authors:  Thekkuttuparambil A Ajith; Kainoor K Janardhanan
Journal:  J Clin Biochem Nutr       Date:  2007-05       Impact factor: 3.114

10.  Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.

Authors:  Zhe Cai; Chun Kwok Wong; Jie Dong; Delong Jiao; Man Chu; Ping Chung Leung; Clara Bik San Lau; Ching Po Lau; Lai Shan Tam; Christopher Wai Kei Lam
Journal:  Chin Med       Date:  2016-04-29       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.